Steve Kirsch discusses the new "Covid-19 Bivalent" boosters with Dr. Kelly Victory, a residency trained and boarded trauma and emergency specialist with over 30 years of clinical experience.
The Pfizer CEO, Albert Bourla, cancelled his participation in yesterday's EU COVID-19 special committee‼️ Therefore, together with some colleagues, I had initiated the action "Pfizer-CEO? - Where is transparency?"
"mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."